Menu

Antarctic Lake Teems With Life

DNA and RNA sequences from Lake Vostok below the Antarctic glacier reveal thousands of bacteria species, including some commonly found in fish digestive systems.

Jul 9, 2013
Chris Palmer

The location of Lake Vostok in East AntarcticaNASAIn an environment most scientists thought was so completely inhospitable to life that it was once considered a model for other planets, scientists have unearthed a vast web of organisms. Biologists sequencing DNA and RNA found in ice core samples taken near the surface of Antarctica’s subglacial Lake Vostok have identified thousands of bacteria species, as well as a smaller number of fungi, and a handful of archaea—primitive, single-cell microbes. Several of the microbes are commonly found in the digestive tracts of both freshwater and marine species, pointing to the presence of complex life such as mollusks, crustaceans, annelid worms, and fish. The findings were reported last Wednesday (July 3) in PLOS ONE.

“We found much more complexity than anyone thought,” senior author Scott Rogers, a biologist at Bowling Green State University, said in a statement. “It really shows the tenacity of life, and how organisms can survive in places where a couple dozen years ago we thought nothing could survive.”

Lake Vostok is the largest of 375 or so subglacial lakes in Antarctica. It is also the fourth deepest lake on Earth, with depths reaching 800 meters from the lake’s surface, itself covered by 2 miles of ice that separate it from the ocean and atmosphere. Rogers said in the statement that the presence of freshwater and marine species would support the hypothesis that the vast lake was once connected to the ocean, and that its freshwater was deposited by an overriding glacier.

Among the microbial species the researchers identified are cold-loving psychrophiles, as well as heat-loving thermophiles, which suggest the presence of volcanic hydrothermal vents deep in the lake. The authors wrote in the paper that the vents could “provide sources of energy and nutrients vital for organisms living in the lake.”

The authors also caution that there is a small chance that the biological material they found may represent previous contamination of the lake.

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

Overcoming the Efficiency Challenge in Clinical NGS
Overcoming the Efficiency Challenge in Clinical NGS
Download this white paper to see how an ECS lab serving a network of more than 10,000 healthcare providers integrated QIAGEN Clinical Insight (QCI) Interpret to significantly reduce manual variant curation efforts and increase workflow efficiency by 80%!
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas Launches Product Portfolio to Mitigate Biotin Interference and Improve Diagnostic Assay Accuracy
Veravas, Inc., an emerging diagnostic company, launched a portfolio of products that can improve the accuracy of current diagnostic test results by helping laboratory professionals detect and manage biotin interference in patient samples with VeraTest Biotin and VeraPrep Biotin.
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
New Data on Circulating Tumor DNA as a Biomarker for Detecting Cancer Progression Presented at 2019 ASCO Annual Meeting
Scientists presented more than 30 abstracts featuring Bio-Rad’s Droplet Digital PCR (ddPCR) technology at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, May 31–June 4.
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
BellBrook Labs Receives NIH Grant for the Discovery of cGAS Inhibitors to Treat Autoimmune Diseases
The National Institute Of Allergy And Infectious Disease recently awarded BellBrook Labs a $300,000 Small Business Innovative Research (SBIR) grant to develop novel inhibitors for the target cyclic GAMP Synthase (cGAS). The grant will be used to accelerate the discovery of new treatments for autoimmune diseases by targeting the cGAS-STING pathway.